Similarly, an alternative therapeutic approach to JAKi would be the use of NGF and EGF treatments to enhance protein translation pathways in MDS because global protein levels are lower in MDS cells (Fig. 4b–c) [47]. The gene discussed is EGF; the disease is myelodysplastic syndrome.